Moderna, Inc. (MRNA) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $12.34B | -12.8% |
| 2024 | $14.14B | -23.2% |
| 2023 | $18.43B | -28.7% |
| 2022 | $25.86B | +4.8% |
| 2021 | $24.67B | +236.2% |
| 2020 | $7.34B | +361.6% |
| 2019 | $1.59B | -19.0% |
| 2018 | $1.96B | +80.9% |
| 2017 | $1.08B | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $12.34B | -12.8% |
| 2024 | $14.14B | -23.2% |
| 2023 | $18.43B | -28.7% |
| 2022 | $25.86B | +4.8% |
| 2021 | $24.67B | +236.2% |
| 2020 | $7.34B | +361.6% |
| 2019 | $1.59B | -19.0% |
| 2018 | $1.96B | +80.9% |
| 2017 | $1.08B | — |